Titin antisense1 (TTN-AS1), a highly expressed lncRNA in breast cancer tumors, has been found to facilitate cell proliferation in breast cancer by competitively sponging miR-524-5p to upregulate the ribonucleotide reductase subunit 2 (RRM2) [28]. Here, TTN is linked to breast carcinoma.